Symbiotic is a decentralized clinical trial platform (DCT) built on blockchain. We are a two-sided platform connecting participants with biopharma, organic medicine manufacturers, med-tech, big tech and academic institutions.
Our mission is to accelerate therapeutic medicine development globally.
Consumer-centric, remote, tablet & mobile-based system.
Blockchain enabled cryptographic security, zero ransomware attacks.
Built on the blockchain with integrated governance and permission controls.
Smart contract automated execution for Enrollment, EDC and payment cycles.
A remote decentralized clinical trial platform that connects individuals and enterprises.
Design the most complex yet easy to use trial surveys and forms with advanced calculations and logic features.
Recruit, screen, and consent research participants with an easy-to-use custom web portal.
Automated consent and data capture experience from anywhere in the world.
Clean, actionable and immutable trial data to help you through key decisions.
Participants can retrieve valuable health data instantly and seamlessly from 3rd party EMR systems.
Search for ongoing trials to participate in from any remote location.
A remote decentralized clinical trial platform built on blockchain.
We use blockchain technology as our data transaction and storage layer.
Blockchain network nodes provide a highly scalable API layer through smart contracts.
At each step, keep track and timestamp with blockchain enabled immutable smart contracts.
Symbiotic is a fully integrated, secure, regulatory compliant, remote monitoring, EDC, cloud-based, and distributed-ledger platform to remotely manage clinical trials.
Director of Life Sciences, Leidos
"It is with great pleasure that I support Symbiotic. Leidos, a $10B a year Fortune 500 Company, with over 7,500 employees worldwide, is particularly interested in partnering with Symbiotic to be one of the first companies in the world to use the platform."
Input your search keywords and press Enter.